Delivery Order SPE2DB22D3102-SPE2DB24FK9YA
Award Date 2/5/24
Potential Completion Date 2/27/24
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $3,203.98, is for the delivery of PROQUAD VIALS, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price arrangement with no set-aside designation. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,507.55 Firm Fixed Price Delivery Order is for the provision of PROQUAD VIALS, a type of pharmaceutical product. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,670.90 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has an ultimate completion date of July 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The award, valued at $1,570.54, is a Firm Fixed Price Delivery Order contract with a completion date of June 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,570.54, has a completion date of July 31, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC enables the DLA to...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS pharmaceutical products to the U.S. government. The $1,601.99 firm fixed price Delivery Order was awarded on June 7, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of July 1, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PROQUAD VIALS to support military treatment programs and facilities. The contract, valued at $7,363.93, has a completion date of May 2, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical on March 29, 2024. The $2,557.96 firm fixed price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has an ultimate completion date of April 19, 2024 and does not contain any set-aside designations. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,601.99 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,654.33, is a delivery order for PROQUAD VIALS and has a completion date of February 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...